发明名称 Vaccine compositions for treating coronavirus infection
摘要 <p>The present disclosure relates to compositions and methods for treating or preventing coronavirus infections. For example, compositions are provided that comprise a coronavirus S protein or N protein, fragment, or variant thereof, capable of eliciting a protective humoral and/or cell-mediated immune response, which compositions are useful for treating or preventing infection by coronavirus, such as the causative agent of SARS. Also, coronavirus S protein and N protein immunogen compositions are provided that include an adjuvant, such as Proteosome or Protollin, which may be used for treating or preventing infection caused by a coronavirus, such as a SARS coronavirus.</p>
申请公布号 AU2005319716(A1) 申请公布日期 2006.06.29
申请号 AU20050319716 申请日期 2005.06.30
申请人 ID BIOMEDICAL CORPORATION OF QUEBEC 发明人 DAVID S. BURT;MARY CHAOHONG HU;DAVID HUGH JONES;GEORGE H. LOWELL;MARK A. REDDISH
分类号 A61K39/215;C07K14/165 主分类号 A61K39/215
代理机构 代理人
主权项
地址